SSStephen Alan Sands

Stephen Alan Sands

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephen Alan Sands has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • James Garvin

    Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Medical Center, New York, New York

    2 shared publications
  • Keith P. Pasichow

    Department of Pediatrics, Steven and Alexandra Cohen Children’s Medical Center of New York, North Shore—Long Island Jewish Health System, New York, USA

    2 shared publications
  • Philip Giarraffa

    2 shared publications
  • Amie N. Dave

    Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, New York (J.A.O., A.N.D., S.A.S.); Department of Neurological Surgery, Columbia University Medical Center, New York, New York (J.N.B.)

    1 shared publication
  • Barry Rosenfeld

    Fordham University, New York, NY, USA

    1 shared publication
  • Brad Tallamy

    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY, USA

    1 shared publication

Latest Publications

  • Open Access

    Health-Related Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

    by Monica Bhatia, Elissa Kolva, Laura Cimini, Zhezhen Jin, Prakash Satwani, Mirko Savone, Diane George, James Garvin, Mary Llenell Paz, Courtney Briamonte, et al.


  • Open Access

    Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced delivery

    by Jennifer A. Oberg, Amie N. Dave, Jeffrey N. Bruce, Stephen A. Sands

    Background: Malignant gliomas are highly proliferative, invasive tumors that are resistant to conventional treatment, and disease progression is often accompanied by physical and mental debilitation. Neurocognitive functioning (NCF) and quality of life (QoL) were evaluated as part of a prospective phase Ib dose-escalation study of topotecan by convection-enhanced delivery (CED) for adult patients with recurrent malignant gliomas. Methods: Sixteen patients were enrolled, and NCF and QoL were evaluated using the Cognitive Stability Index and SF-36 at baseline and monthly for 4 months post treatment. Descriptive analyses included the reliable change index for serial evaluations and correlations for associations between outcome variables and age, tumor volume, total topotecan dose, and treatment effect. Results: Individual classifications of response to treatment indicated that a majority of patients reported stable scores over the follow-up period. Demographic and treatment-related variables were not associated with outcomes. Baseline processing speed scores were invalid for 6 subjects. Higher rates of valid scores were observed on subsequent administrations. Conclusions: As the first study to use CED of any kind to evaluate the impact of CED on NCF or QoL, there was no evidence of severe detriment to either outcome. Long-term evaluation is necessary to track changes in NCF and QoL related to disease progression. Invalid scores suggest that computer-based assessments may not be suitable for all patients with malignant gliomas, especially those with cognitive deficits secondary to their disease. Future trials should include a wider range of sensitive measures to assess the impact of CED on patient NCF and QoL.


  • Long-Term Follow-Up of Children Treated for High-Grade Gliomas: Children's Oncology Group L991 Final Study Report

    by Stephen Alan Sands, Tianni Zhou, Sharon Helene O'NEil, Sunita K. Patel, Jeffrey Allen, Patsy McGuire Cullen, Thomas A. Kaleita, Robert Noll, Charles Sklar, Jonathan Lester Finlay

    Purpose: High-grade gliomas of the CNS are characterized by poor treatment response and prognosis for long-term survival. The Children's Oncology Group (COG) L991 study investigated the neuropsychological, behavioral, and quality of life (QoL) outcomes after treatment on the Children's Cancer Group (CCG) trial for high-grade gliomas (CCG-945). Patients and Methods: Fifty-four patients (29 males, 25 females) with a median age of 8.8 years at diagnosis (range, 0.2 to 19.5 years) were enrolled at 25 institutions in North America, representing 81% of available survivors; median length of follow-up was 15.1 years (range, 9.5 to 19.2 years), and median age at study evaluation was 23.6 years (range, 11.3 to 36 years). Standardized tests of neuropsychological functioning and QoL were performed. Descriptive statistics summarized principal findings, and one-way analysis of variance identified potential predictors of outcomes. Results: With an average follow-up time of 15 years, survivors demonstrated intellectual functioning within the low-average range. Executive functioning and verbal memory were between the low-average and borderline ranges. In contrast, visual memory and psychomotor processing speed were between the borderline and impaired ranges, respectively. Approximately 75% of patient reported overall QoL within or above normal limits for both physical and psychosocial domains. Nonhemispheric tumor location (midline or cerebellum), female sex, and younger age at treatment emerged as independent risk factors. Conclusion: These results serve as a benchmark for comparison with future pediatric high-grade glioma studies, in addition to identifying at-risk cohorts that warrant further research and proactive interventions to minimize late effects while striving to ensure survival.


  • Concordance of quality of life assessments following pediatric hematopoietic stem cell transplantation

    by Rosemarie E. Feichtl, Barry Rosenfeld, Brad Tallamy, Mitchell S. Cairo, Stephen A. Sands

    Purpose: To examine the concordance between pediatric patient's self-report and parent-report regarding a patient's quality of life (QoL) prior to and following hematopoietic stem cell transplantation (HSCT) and to identify potential medical and demographic covariates of concordance. Patients and Methods: Utilizing the PedsQL 4.0, the longitudinal QoL data were obtained from 68 pediatric HSCT patient–parent dyads prior to and up to two years post-transplantation. Results: Reliability based upon Intraclass Correlation Coefficients (ICC) indicates a parabolic pattern of concordance being significantly poorer in the acute phase of treatment 3 months post-HSCT, followed by a return to pre-transplant levels at subsequent assessments and a substantial rise at one- and two-year follow-up assessments (Baseline ICC = 0.42; 3 months = 0.11; 6 months = 0.54). Paired t-tests further indicate that concordance was highest for observable domains of functioning (Physical and School) with greater inter-rater discrepancies on the subjective domains (Emotional and Social) of QoL at baseline and 6 months post-transplantation. Conclusion: Children typically rated their QoL as higher than parents at all time points and in virtually all domains; however, both perspectives are vital in providing a more accurate depiction of a patient's treatment experience. Dyads speaking the same language exhibited higher levels of QoL agreement than those that did not, while concordance among female-patient-dyads was more disparate than male-patient-dyads. Such findings highlight the importance of implementing psychosocial assessments and possible interventions for patients and parents proactively during the HSCT to effectively address the impact of the treatment and recovery experiences. Copyright © 2009 John Wiley & Sons, Ltd.


  • Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivors

    by Stephen A. Sands, Keith P. Pasichow, Rebecca Weiss, James Garvin, Sharon Gardner, Ira J. Dunkel, Jonathan L. Finlay


  • Familial dysautonomia's impact on quality of life in childhood, adolescence, and adulthood

    by Stephen A. Sands, Philip Giarraffa, Colleen M. Jacobson, Felicia B. Axelrod

    Aim: To evaluate the quality of life (QoL) of children, adolescents, and adults treated for familial dysautonomia (FD), a pervasive neurological disorder. Methods: The Child Health Questionnaire was completed by parents of 71 patients, while an additional 74 patients completed the Short Form – 36. Results: FD imposed a greater physical than psychosocial burden on the child, while the young adults reported both mental and physical quality of life within the average range. Self‐esteem was problematic and improved with age, while both groups reported lowering physical quality of life as they grew older, with worsening general health that limited their role at school or work. Conclusion: Younger FD patients should be closely monitored for lowered self‐esteem and referred for counseling when appropriate, while physical and occupational therapy should be provided in advance of expected lowered physical QoL and role fulfillment with increasing age. This becomes important as the need for additional surgical interventions, such as fundoplication with gastrostomy or spinal fusion, contribute to lower physical functioning. Given the high degree of parental involvement required for the varied manifestations of this multisystem disorder, the need for continued parental assessment and psycho‐education about this chronic medical illness is warranted.


  • Familial dysautonomia's impact on quality of life in childhood, adolescence, and adulthood

    by Stephen Sands, Philip Giarraffa, Colleen Jacobson, Felicia Axelrod

    To evaluate the quality of life (QoL) of children, adolescents, and adults treated for familial dysautonomia (FD), a pervasive neurological disorder. The Child Health Questionnaire was completed by parents of 71 patients, while an additional 74 patients completed the Short Form--36. FD imposed a greater physical than psychosocial burden on the child, while the young adults reported both mental and physical quality of life within the average range. Self-esteem was problematic and improved with age, while both groups reported lowering physical quality of life as they grew older, with worsening general health that limited their role at school or work. Younger FD patients should be closely monitored for lowered self-esteem and referred for counseling when appropriate, while physical and occupational therapy should be provided in advance of expected lowered physical QoL and role fulfillment with increasing age. This becomes important as the need for additional surgical interventions, such as fundoplication with gastrostomy or spinal fusion, contribute to lower physical functioning. Given the high degree of parental involvement required for the varied manifestations of this multisystem disorder, the need for continued parental assessment and psycho-education about this chronic medical illness is warranted.


  • Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma

    by Stephen A. Sands, Jessica S. Milner, Judith Goldberg, Vandana Mukhi, Jennifer A. Moliterno, Carol Maxfield, Jeffrey H. Wisoff

    Object: The authors set out to evaluate the quality of life (QOL), social—emotional functioning, and behavioral functioning of children treated surgically for craniopharyngiomas. Methods: Twelve girls and 17 boys with a mean age at diagnosis of 8 ± 3.8 years were surgically treated between 1985 and 1998 at the New York University Medical Center. After a mean follow-up period of 6.8 ± 3.5 years, these 29 patients were administered either the 36-item Short Form Health Survey version 2 or the Child Health Questionnaire—Parent Form to assess QOL, as well as the Achenbach Child Behavior Checklist or Young Adult Checklist to measure social—emotional and behavioral functioning. Patients older than 19 years of age and parents of patients younger than 19 years of age reported low average overall physical QOL, with overall psychosocial QOL in the average range. Behavioral difficulties were noted, including internalizing, attention, somatic, and social difficulties. Further analyses indicated that retrochiasmatic tumor location, recurrence, and additional surgery were associated with poorer outcomes. In contrast, hydrocephalus, tumor size, and sex were not prognostic variables, and patients significantly improved as postoperative time increased. Conclusions: Attention toward late effects arising after the treatment of pediatric craniopharyngioma, including decreased postoperative physical health and behavioral functioning, is warranted. Future approaches to treatment should consider the documented effects of either gross-total resection or limited surgery followed by cranial irradiation on QOL, with specific evaluation for those with retrochiasmatic tumors, a recurrent tumor, or the need for additional surgery. Psychosocial QOL and social—emotional functioning should be maintained through ongoing counseling and education.